However, even this option is associated with the increased risk of intracerebral hemorrhage.

Objective: To determine whether antiplatelet therapy increases the risk of recurrent intracerebral hemorrhage.

One patient experienced symptomatic intracerebral hemorrhage within a region of recurrent MRI hyperintensity.

Algorithm 3 had the highest kappa values for intracerebral hemorrhage and subarachnoid hemorrhage.

Four occurred following combined endarterectomy-coronary bypass surgery, and one was an intracerebral hemorrhage.

Safety outcomes were intracerebral hemorrhage or a recurrence of ischemic stroke.

Likelihood of symptomatic intracerebral hemorrhage is higher in anterior circulation stroke.

A total of 51 cases of intracerebral hemorrhage were included in this study.

Results: Evidence-based guidelines are presented for the care of patients with acute intracerebral hemorrhage.

Conclusions: Intravenous desmopressin was well tolerated and improved platelet activity after acute intracerebral hemorrhage.

These guidelines provide a framework for goal-directed treatment of the patient with intracerebral hemorrhage.

Clear cause of death was herniation of the brain stem due to intracerebral hemorrhage.

The primary safety end point was the incidence of symptomatic intracerebral hemorrhage within 36 hours.

One patient died from intracerebral hemorrhage 11 months post-radiosurgery, and five patients deferred further treatment.

We have previously reported that these strains may be a risk factor for intracerebral hemorrhage.

Stroke also broadly includes intracerebral hemorrhage and subarachnoid hemorrhage.